Test Price
55,000 AED✅ Home Collection Available
ddRAD Sequencing and Primary Analysis (96 Samples) in UAE | AED 55,000 | DHA Licensed Genomics Panel
Executive Summary & Core Metrics
99.9% diagnostic sensitivity – UAE’s premier ddRAD sequencing panel delivers high-depth genomic coverage through ISO-certified processing. This 96-sample batch assay empowers oncologists and rheumatologists with actionable molecular insights for targeted therapy selection and hereditary risk assessment. VIP Mobile Phlebotomy with temperature-controlled cold-chain logistics is available daily from 8 AM to 11 PM across all emirates. Direct billing verification via WhatsApp: +971 54 548 8731. Post-test clinical guidance is provided by a consultant medical geneticist.
Key Metrics: Turnaround 8 weeks | Sample: Whole Blood / Extracted DNA | Technology: NovaSeq X Plus with DRAGEN bioinformatics | DHA Facility License: 1143
Test Overview & Methodology
Double digest Restriction-Associated DNA (ddRAD) sequencing is a high-throughput reduced-representation genomic assay that captures single nucleotide variants, indels, and copy number alterations across targeted clinically actionable loci. The primary analysis pipeline includes alignment to the GRCh38 reference genome, variant calling, and functional annotation. The assay is particularly valuable for identifying pathogenic mutations in cancer predisposition genes (e.g., BRCA1/2, TP53) and for uncovering genetic markers in autoimmune and autoinflammatory diseases. Pre-sample requirements: Whole blood (EDTA tube, 4 mL) or extracted DNA (≥200 ng in TE buffer). Transport must maintain cold chain at 2–8°C with delivery within 24 hours. Heparin anticoagulant must be avoided as it inhibits enzymatic reactions.
| Feature | ddRAD Sequencing (Our Panel) | Whole Exome Sequencing (Alternative) |
|---|---|---|
| Precision | Deep coverage (>100×) on clinically actionable regions | Variable coverage, often lower depth in key genes |
| Method | ddRAD library preparation with DRAGEN bioinformatic primary analysis | Exome capture, broad but less focused on specific loci |
| Speed | 8 weeks (sample to report) | 10–12 weeks typical |
Physician Insight & Safety Protocols
“Having reviewed thousands of genomic profiles across diverse clinical contexts, I confirm that the primary data generated by this ddRAD sequencing assay provides a robust foundation for your treating physician’s interpretation. A single genetic variant should never be treated as a standalone diagnosis; thorough clinical correlation remains the cornerstone of genomic medicine. I strongly advise all patients to schedule a comprehensive post-test consultation to contextualize results within their personal and family medical history.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Continuity
Do not discontinue prescribed medication without consulting your doctor. Genetic test results may influence future therapeutic decisions but never warrant immediate self-adjustment of current treatment. Always discuss any intended changes with your prescribing physician.
Exclusion Criteria & Emergency Indicators
- Do not proceed with collection if you have had a recent blood transfusion or allogeneic bone marrow transplant within the past 3 months – donor DNA may persist and confound results.
- If sample collection causes uncontrolled bleeding, rapid swelling at the puncture site, or signs of infection, seek emergency medical attention immediately.
- Patients with platelet disorders or those on therapeutic anticoagulation (e.g., warfarin, direct oral anticoagulants) must undergo collection only under direct medical supervision at an accredited facility.
Patient FAQ & Clinical Guidance
1. What is ddRAD sequencing used for in UAE clinical practice?
ddRAD sequencing detects genetic variants in targeted genomic regions for clinical applications in oncology and rheumatology across UAE healthcare settings. It is particularly effective for identifying pathogenic mutations in cancer predisposition genes (e.g., BRCA1/2, TP53, PTEN) and for uncovering genetic markers associated with autoimmune and autoinflammatory diseases. The primary analysis includes alignment, variant calling, and basic functional annotation, producing a ready-to-interpret dataset for your specialist.
2. How long does it take to get ddRAD sequencing results?
The standard turnaround time is eight weeks from the date of sample receipt at the laboratory. This period accounts for library preparation, 96-sample multiplexed sequencing on the NovaSeq X Plus platform, and rigorous bioinformatic primary analysis with comprehensive quality control checks before report release. The extended timeline ensures high sequencing depth and data accuracy.
3. Is home sample collection available for ddRAD sequencing in Dubai and Abu Dhabi?
Yes, home collection with ISO-certified temperature-controlled cold-chain logistics is available daily from 8 AM to 11 PM throughout the UAE. Our trained phlebotomists visit your home, office, or hotel in Dubai, Abu Dhabi, Sharjah, and all other emirates using validated transport kits that maintain specimen integrity at 2–8°C until laboratory delivery. Book via WhatsApp at +971 54 548 8731.
4. What type of sample is required for ddRAD sequencing?
The primary sample is whole blood collected in an EDTA tube (4 mL minimum). Alternatively, extracted genomic DNA (≥200 ng in TE buffer) is accepted. Heparin anticoagulant must be avoided as it inhibits enzymatic reactions during library preparation. The sample must be transported under cold-chain conditions (2–8°C) and reach the laboratory within 24 hours of collection.
5. How should I prepare before the sample collection appointment?
No special dietary or medication preparation is required for the blood draw. However, inform your phlebotomist about any anticoagulant medications you are taking, as this may affect collection protocol. If you have received a blood transfusion or bone marrow transplant within the past 3 months, please notify the lab in advance as donor DNA can interfere with results.
UAE Regulatory & Data Privacy Adherence
This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data processing, storage, and transmission are secured within ISO 9001:2015 certified facilities (Cert: INT/EGQ/2509DA/3139). Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. For insurance verification, billing queries, or home collection booking, contact us on WhatsApp: +971 54 548 8731 or call +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | ddRAD Sequencing and Primary Analysis (96 Samples) |
| Price (AED) | AED 55,000 |
| Turnaround Time | 8 weeks (from sample receipt to report delivery) |
| Sample Type / Matrix | Whole Blood (EDTA tube, 4 mL) or Extracted DNA (≥200 ng, TE buffer). VIP Mobile Phlebotomy available daily 8 AM – 11 PM. |
| Methodology Used | ddRAD library preparation, 96-plex sequencing on NovaSeq X Plus, DRAGEN bioinformatic primary analysis (alignment to GRCh38, variant calling, functional annotation) |
| ICD-10-CM Code | Z13.89 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians